Hepatitis B validity of drug users' self-report

Psychology of Addictive Behaviors

Volumn 13, Issue 1, 1999, Pages 33-38

  Fisher, Dennis G ^a   Kuhrt Hunstiger, Teresa I ^b   Orr, Sylvia M ^b   Davis, Dawn C ^b  

^a UNIVERSITY OF ALASKA ANCHORAGE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; COCAINE; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY; MORPHINE;

ARTICLE; DRUG USE; FEMALE; HEPATITIS B; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; SELF REPORT; VALIDATION PROCESS;

EID: 0033062886     PISSN: 0893164X     EISSN: None     Source Type: Journal    
DOI: 10.1037/0893-164X.13.1.33     Document Type: Article

References (36)

1. Ball, J. C. (1967). The reliability and validity of interview data obtained from 59 narcotic drug addicts. American Journal of Sociology, 72, 650-654.
2. Bonito, A. J., Nurco, D. N., & Shaffer, J. W. (1976). The veridicality of addicts' self-reports in social research. The International Journal of the Addictions, 11, 719-724.
3. Brooks, K., Orr, S., Fenaughty, A., & Fisher, D. (1994). ALT as a surrogate marker for hepatitis B and C among drug users [Abstract]. Abstracts of the 122nd Annual Meeting and Exhibition of the American Public Health Association, Washington, DC, Session 1017, 12.
4. Comfort, M. B., & Wu, P. C. (1989). The reliability of personal and family medical histories in the identification of hepatitis B carriers. Oral Surgery, Oral Medicine, Oral Pathology, 67, 531-534.
5. Dowling-Guyer, S., Johnson, M. E., Fisher, D. G., Needle, R., Watters, J., Andersen, M., Williams, M., Kotranski, L., Booth, R., Rhodes, F., Weatherby, N., Estrada, A. L., Fleming, D., Deren, S., & Tortu, S. (1994). Reliability of drug users' self-reported HIV risk behaviors and validity of self-reported recent drug use. Assessment, 1(4), 383-392.
6. Fisher, D. G., & Kuhrt-Hunstiger, T. I. (1993). Prevalence and risk factors for hepatitis B in IVDUs [Abstract]. Abstracts of the American Public Health Association 121st Annual Meeting and Exhibition, San Francisco, CA, Session 2072, 143.
7. Fisher, D. G., Needle, R., Weatherby, N., Brown, B., Booth, R., & Williams, M. (1993). Reliability of drug users self-report [Abstract]. IXth International Conference on AIDS, Berlin, Germany (PO-C35-3355).
8. Goldstein, M. F., Friedman, S. R., Neaigus, A., Jose, B., Ildefonso, G., & Curtis, R. (1995). Self-reports of HIV risk behavior by injecting drug users: Are they reliable? Addiction, 90, 1097-1104.
9. Hart, G. J., Dawson, J., Fitzpatrick, R. M., Boulton, M., McLean, J., Brookes, M., & Parry, J. V. (1993). Risk behavior, anti-HIV and anti-hepatitis B core prevalence in clinic and non-clinic samples of gay men in England. AIDS, 7, 863-869.
10. Heyward, W. L., Bender, T. R., McMahon, B. J., Hall, D. B., Francis, D. P., Lanier, A. P., Alward, W. L., Ahtone, J. L., Murphy, B. L., & Maynard, J. E. (1985). The control of hepatitis B virus infection with vaccine in Yupik Eskimos. Demonstration of safety, immunogenicity, and efficacy under field conditions. American Journal of Epidemiology, 121(6), 914-923.
11. Joe, G. W., Copher, J. L., Menon, R., & Simpson, D. D. (1990). Needle use and sex risk indices: A methodological report. NIDA/NADR Research in Progress: Research Summaries From the Southwest Regional Research Group, December, 7-10.
12. Kleyn, J., Schwebke, J., & Holmes, K. K. (1993). The validity of injecting drug users' self-reports about sexually transmitted diseases: A comparison of survey and serological data. Addictions, 88, 673-680.
13. Kuhrt-Hunstiger, T. I., & Fisher, D. G. (1993). Risk factors for hepatitis B in Alaskan IVDU's [Abstract]. IXth International Conference on AIDS, Berlin, Germany (PO-A36-0841).
14. Kuhrt-Hunstiger, T. I., & Fisher, D. G. (1994a). Hepatitis B: How unique is Alaska? [Abstract]. Abstracts of the 122nd Annual Meeting and Exhibition of the American Public Health Association, Washington, DC, Session 3106, 310.
15. Kuhrt-Hunstiger, T. I., & Fisher, D. G. (1994b). Risk factors for hepatitis B in Alaskan IVDU's. Arctic Medical Research, 53 (Suppl. 2), 625-627.
16. Kuzma, J. W. (1992). Basic statistics for the health sciences. Mountain View, CA: Mayfield.
17. Levine, O. S., Vlahov, D., Koehler, J., Cohn, S., Spronk, A. M., & Nelson, K. E. (1995). Seroepidemiology of hepatitis B virus in a population of injecting drug users: Association with drug injection patterns. American Journal of Epidemiology, 142(3), 331-341.
18. Magura, S., Goldsmith, D., Casriel, C., Goldstein, P. J., & Lipton, D. S. (1987). The validity of methadone clients' self-reported drug use. The International Journal of the Addictions, 22, 727-749.
19. McMahon, B. J., Helminiak, C., Wainwright, R. B., Bulkow, L., Trimble, B. A., & Wainwright, K. (1992). Frequency of adverse reactions to hepatitis B vaccine in 43,618 persons. American Journal of Medicine, 92(3), 254-256.
20. McMahon, B. J., Rhoades, E. R., Heyward, W. L., Tower, E., Ritter, D., Lanier, A. P., Wainwright, R. B., & Helminiak, C. (1987). A comprehensive programme to reduce the incidence of hepatitis B virus infection and its sequelae in Alaskan natives. Lancet, 2(8568), 1134-1136.
21. McMahon, B. J., Wainwright, K., Bulkow, L., Parkinson, A. J., Lindenbaum, M., Wainwright, R., & Helminiak, C. (1990). Response to hepatitis B vaccine in Alaska natives with chronic alcoholism compared with non-alcoholic control subjects. American Journal of Medicine, 88(5), 460-464.
22. National Institute on Drug Abuse. (1989a). NIDA's national AIDS outreach demonstration research projects. NIDA Notes, 4.
23. National Institute on Drug Abuse. (1989b). NIDA outreach demonstration projects provide insight into AIDS risk behaviors. NIDA Notes, 4, 1-9.
24. National Institute on Drug Abuse. (1991). Risk Behavior Assessment. Rockville, MD: Author.
25. Needle, R., Fisher, D. G., Weatherby, N., Chitwood, D., Brown, B., Cesari, H., Booth, R., Williams, M. L., Watters, J., Anderson, M., & Braunstein, M. (1995). The reliability of self-reported HIV risk behaviors of drug users. Psychology of Addictive Behaviors, 9(4), 242-250.
26. Nevid, J. S., & Gotfried, F. (1993). A student's guide to AIDS and other sexually transmitted diseases. Needham Heights, MA: Allyn & Bacon.
27. Orr, S. M., Fenaughty, A. M., & Fisher, D. G. (1994). Predictors for anti-hepatitis C in IVDU's and crack cocaine smokers [Abstract]. Abstracts of the 122nd Annual Meeting and Exhibition of the American Public Health Association, Washington, DC, Session 2002, 105.
28. Osmond, D. H., Charlebois, E., Sheppard, H. W., Page, K., Winkelstein, W., Moss, A. R., & Reingold, A. (1993). Comparison of risk factors for hepatitis C and hepatitis B virus infection in homosexual men. The Journal of Infectious Diseases, 167, 66-71.
29. Rosenblum, L., Darrow, W., Witte, J., Cohen, J., French, J., Gill, P. S., Potterat, J., Sikes, K., Reich, R., & Hadler, S. (1992). Sexual practices in the transmission of hepatitis B virus and prevalence of hepatitis delta virus infection in female prostitutes in the United States. Journal of the American Medical Association, 267(18), 2477-2481.
30. Simpson, D. D., Knight, K., & Ray, S. (1993). Psychosocial correlates of AIDS-risk drug use sexual behaviors. AIDS Education and Prevention, 5, 121-130.
31. Stephens, R. (1972). The truthfulness of addict respondents in research projects. The International Journal of the Addictions, 7, 549-558.
32. Tseng, C. H., Villanueva, T. G., & Powell, A. (1987). Sexually transmitted diseases: A handbook of protection, prevention and treatment. Saratoga, CA: R&E.
33. Wainwright, R. B., McMahon, B. J., Bulkow, L. R., Hall, D. B., Fitzgerald, M. A., Harpster, A. P., Hadler, S. C., Lanier, A. P., & Heyward, W. L. (1989). Duration of immunogenicity and efficacy of hepatitis B vaccine in a Yupik Eskimo population. Journal of the American Medical Association, 261(16), 2362-2366.
34. Wainwright, R. B., McMahon, B. J., Bulkow, L. R., Parkinson, A. J., & Harpster, A. P. (1991). Protection provided by hepatitis B vaccine in a Yupik Eskimo population. Seven-year results. Archives of Internal Medicine, 151(8), 1634-1636.
35. Watters, J. K., & Biernacki, P. (1989). Targeted sampling: Options for the study of hidden populations. Social Problems, 36(4), 416-430.
36. Weatherby, N. L., Needle, R., Cesari, H., Booth, R., McCoy, C. B., Watters, J. K., Williams, M., & Chitwood, D. D. (1994). Validity of self-reported drug use among injection drug users and crack cocaine users recruited through street outreach. Evaluation and Program Planning, 17(4), 347-355.